OTC: IPSEF - Ipsen S.A.

छह महीने के लिए लाभप्रदता: +2.5%
भाग प्रतिफल: +0.96%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Ipsen S.A.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में Ipsen S.A.

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Dysport for motor muscular disorders and medical aesthetics; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; and Tazverik to treat third-line follicular lymphoma.

अधिक जानकारी
The company also provides NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome or chronic renal insufficiency, and GH deficiency in adults; and Increlex for growth failure in children and adolescents. In addition, it offers Xermelo for the treatment of carcinoid syndrome; and Cometriq to treat medullary thyroid cancer. Ipsen S.A. has agreements with Debiopharm; Exelixis; Galderma; Blueprint Medicines; TerSera Therapeutics; Rhythm Pharmaceuticals; Teijin; Schwabe; BAKX Therapeutics Inc.; and Exicure. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета eur
Див.доход ао 0.9639
Дивиденд ао 1.16
Сайт https://www.ipsen.com
Цена ао 120.55
प्रति दिन मूल्य परिवर्तन: 0% (120.55)
प्रति सप्ताह मूल्य परिवर्तन: 0% (120.55)
प्रति माह मूल्य परिवर्तन: 0% (120.55)
3 महीने में कीमत में बदलाव: -3.84% (125.37)
छह महीने में कीमत में बदलाव: +2.5% (117.61)
प्रति वर्ष मूल्य परिवर्तन: +2.51% (117.6)
वर्ष की शुरुआत से मूल्य परिवर्तन: -3.84% (125.37)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 2.63 6
P/BV 2.15 7
P/E 12.77 8
EV/EBITDA 8.63 8
कुल: 7.88

क्षमता

नाम अर्थ श्रेणी
ROA, % 10.19 4
ROE, % 16.85 5
कुल: 5

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0.9639 2.4
DSI 0.8571 8.57
कुल: 2.86

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA 0.4137 10
कुल: 9.8

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 22.79 4
लाभप्रदता Ebitda, % 4.08 1
लाभप्रदता EPS, % -1246.72 0
कुल: 2.8
अधिक जानकारी



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. David Loew MD, CEO & Director 2.41M 1967 (58 साल)
Mr. Aymeric Le Chatelier Executive VP & CFO 792.51k 1969 (56 साल)
Dr. Aidan Murphy Ph.D. Executive VP and Head of Technical Operations N/A 1966 (59 साल)
Mr. Craig Marks Vice-President of Investor Relations N/A
Mr. Francois Garnier Executive VP of Legal Affairs, General Counsel & Chief Business Ethics Officer N/A 1962 (63 वर्ष)
Mr. Regis Mulot Executive VP & Chief Human Resources Officer N/A 1966 (59 साल)
Ms. Dominique Bery Head of Nordics & Baltics N/A 1971 (54 वर्ष)
Mr. Bartosz Bednarz D.D.S. Executive VP and Head of Global Product & Portfolio Strategy N/A
Mr. Philippe Lopes-Fernandes CBO Executive VP & Chief Business Officer N/A
Dr. James Levine M.D., Ph.D. President of Fondation Ipsen

पता: France, Boulogne-Billancourt, 65 quai Georges Gorse - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.ipsen.com